Lunai Bioworks Advances Oncology with AI Pilot Collaboration for Colorectal Cancer Analysis Lunai Bioworks has initiated a groundbreaking AI-driven oncology pilot to analyze data from a metastatic colorectal cancer trial, aiming to enhance patient outcomes.

Lunai Bioworks Advances Oncology with AI Pilot Collaboration for Colorectal Cancer Analysis #USA #Sacramento #Colorectal_Cancer #AI_oncology #Lunai_Bioworks

Lumonus Secures A$25 Million Series B Funding to Enhance AI-Powered Oncology Workflows Worldwide Lumonus has successfully raised A$25 million in Series B funding to scale its AI-driven oncology workflows globally. The funds will accelerate product innovation and clinical success.

Lumonus Secures A$25 Million Series B Funding to Enhance AI-Powered Oncology Workflows Worldwide #Australia #Sydney #Series_B_Funding #AI_oncology #Lumonus

SOPHiA GENETICS Reveals Impressive Financial Performance for Q2 2025 SOPHiA GENETICS announces robust Q2 2025 financial results, showcasing a 16% revenue increase and strategic partnerships solidifying its market position.

SOPHiA GENETICS Reveals Impressive Financial Performance for Q2 2025 #None #SOPHiA_GENETICS #MSK-ACCESS #AI_oncology